Urinary Proteomics Combined With Home Blood Pressure Telemonitoring for Health Care Reform

Launched by KU LEUVEN · Mar 5, 2020

Keywords

ClinConnect Summary

The UPRIGHT-HTM trial is studying a new way to monitor and treat patients with health conditions related to high blood pressure and protein levels in urine. Researchers want to see if combining home blood pressure monitoring with a special urine test can help identify patients at higher risk for health problems more effectively than just monitoring blood pressure alone. This could lead to better treatment plans and potentially reduce healthcare costs, while also empowering patients to take an active role in managing their health.

To participate in this study, you would need to have at least three risk factors for heart problems, like high blood pressure or type 2 diabetes. You'll also need to be comfortable taking your blood pressure at home every day and have access to the internet through a device like a smartphone or computer. If you join the study, you can expect to follow a specific plan for monitoring your health over time. However, there are some exclusions, like having type 1 diabetes or certain serious illnesses, so it's best to check if you meet the criteria before considering participation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must have at least three additional guideline-defined risk factors, preferably including hypertension, type 2 diabetes mellitus (T2DM), or both;
• • Patients should be willing patients to engage for the duration of the study in home blood pressure telemonitoring (1 reading per day);
• • Patients must have an email address and internet access via smartphone, tablet, or laptop or desktop computer;
• • Patients should comply with the study protocol during the run-in phase.
• Exclusion Criteria:
• • Type 1 diabetes mellitus;
• • Absence of a practicable echocardiographic window;
• • Previous or concurrent severe cardiovascular or non-cardiovascular disease;
• • Cancer within 5 years of enrolment;
• • Suspected substance abuse;
• • Psychiatric illness;
• • Use of nephrotoxic drugs;
• • Particpation in another clinical study.